Clinical applications of cell-free fetal DNA from maternal plasma

Obstetrics and Gynecology

Volumn 103, Issue 1, 2004, Pages 157-164

  Rijnders, Robbert J P ^a   Christiaens, Godelieve C M L ^b   Bossers, Bernadette ^b   Van Der Smagt, Jasper J ^b   Van Der School, C Ellen ^b   De Haas, Masja ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL FREE FETAL DNA; DNA; RHESUS D ANTIBODY; UNCLASSIFIED DRUG; HYBRID PROTEIN; ONCOPROTEIN; PRIMER DNA; RHD FUSION PROTEIN, HUMAN; RHO(D) ANTIGEN;

ARTICLE; BLOOD GROUP RHESUS SYSTEM; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FETUS; GENE SEQUENCE; HUMAN; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEX DETERMINATION; SRY GENE; BLOOD; EVALUATION; GENDER AND SEX; GENETICS; METHODOLOGY; NEWBORN; NEWBORN HEMOLYTIC DISEASE; POLYMERASE CHAIN REACTION; PREDICTION AND FORECASTING; PREGNANCY; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY; STANDARD;

DNA; DNA PRIMERS; ERYTHROBLASTOSIS, FETAL; FEMALE; GENES, SRY; HUMANS; INFANT, NEWBORN; MALE; ONCOGENE PROTEINS, FUSION; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PREGNANCY; PRENATAL DIAGNOSIS; RECOMBINANT FUSION PROTEINS; RH-HR BLOOD-GROUP SYSTEM; SENSITIVITY AND SPECIFICITY; SEX DETERMINATION (GENETICS);

EID: 0742333328     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000103996.44503.F1     Document Type: Article

References (23)

1. Yamada T, Nakamori S, Ohzato H, Oshima S, Aoki T, Higaki N, et al. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features. Clin Cancer Res 1998;4:1527-32.
2. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-7.
3. Rijnders RJ, van der School CE, Bossers B, de Vroede MA, Christiaens GC. Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia. Obstet Gynecol 2001;98:374-8.
4. Lo YM, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998;339:1734-8.
5. Amicucci P, Gennarelli M, Novelli G, Dallapiccola B. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem 2000;46:301-2.
6. Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768-75.
7. Verhagen OJ, Willemse MJ, Breunis WB, Wijkhuijs AJ, Jacobs DC, Joosten SA, et al. Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia. Leukemia 2000;14:1426-35.
8. Maaskant-Van Wijk PA, Faas BH, de Ruijter JA, Overbeeke MA, dem Borne AE, van Rhenen DJ, et al. Genotyping of RHD by multiplex polymerase chain reaction analysis of six RHD-specific exons. Transfusion 1998;38:1015-21.
9. Gardner MJ, Altman DG. Statistics with confidence. London: British Medical Journal Publishers; 1989.
10. Legier TJ, Maas JH, Kohler M, Wagner T, Daniels GL, Perco P, et al. RHD sequencing: a new tool for decision making on transfusion therapy and provision of Rh prophylaxis. Transfus Med 2001;11:383-8.
11. Tax MG, van der Schoot CE, van Doorn R, Douglas-Berger L, van Rhenen DJ, Maaskant-vanWijk PA. RHC and RHc genotyping in different ethnic groups. Transfusion 2002;42:634-44.
12. Johnson JM, Wilson RD, Singer J, Winsor E, Harman C, Armson BA, et al. Technical factors in early amniocentesis predict adverse outcome: results of the Canadian Early (EA) versus Mid-trimester (MA) Amniocentesis Trial. Prenat Diagn 1999;19:732-8.
13. Costa JM, Benachi A, Gautier E, Jouannic JM, Ernault P, Dumez Y. First-trimester fetal sex determination in maternal serum using real-time PCR. Prenat Diagn 2001;21:1070-4.
14. Honda H, Miharu N, Ohashi Y, Ohama K. Successful diagnosis of fetal gender using conventional PCR analysis of maternal serum. Clin Chem 2001;47:41-6.
15. Honda H, Miharu N, Ohashi Y, Samura O, Kinutani M, Hara T, et al. Fetal gender determination in early pregnancy through qualitative and quantitative analysis of fetal DNA in maternal serum. Hum Genet 2002;110:75-9.
16. Houfflin-Debarge V, O'Donnell H, Overton T, Bennett PR, Fisk NM. High sensitivity of fetal DNA in plasma compared to serum and nucleated cells using unnested PCR in maternal blood. Fetal Diagn Ther 2000;15:102-7.
17. Sekizawa A, Kondo T, Iwasaki M, Watanabe A, Jimbo M, Saito H, et al. Accuracy of fetal gender determination by analysis of DNA in maternal plasma. Clin Chem 2001;47:1856-8.
18. Zhong XY, Holzgreve W, Hahn S. Risk free simultaneous prenatal identification of fetal Rhesus D status and sex by multiplex real-time PCR using cell free fetal DNA in maternal plasma. Swiss Med Wkly 2001;131:70-4.
19. van der Schoot CE, Tax GH, Rijnders RJ, De Haas M, Christiaens GC. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed. Transfus Med Rev 2003;17:31-44.
20. Gonzalez-Gonzalez MC, Garcia-Hoyos M, Trujillo MJ, Rodriguez DA, Lorda-Sanchez I, Diaz-Recasens J, et al. Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat Diagn 2002;22:946-8.
21. Gonzalez-Gonzalez MC, Trujillo MJ, Rodriguez DA, Garcia-Hoyos M, Lorda-Sanchez I, Diaz-Recasens J, et al. Huntington disease-unaffected fetus diagnosed from maternal plasma using QF-PCR. Prenat Diagn 2003;23:232-4.
22. Finning KM, Martin PG, Soothill PW, Avent ND. Prediction of fetal D status from maternal-plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 2002;42:1079-85.
23. Alizadeh M, Bernard M, Danic B, Dauriac C, Birebent B, Lapart C, et al. Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. Blood 2002;99:4618-25.